Related Experiment Video
Updated: Aug 22, 2025

Magnetic Adjustment of Afterload in Engineered Heart Tissues
Published on: May 5, 2020
Altered Cellular Protein Quality Control System Modulates Cardiomyocyte Function in Volume Overload-Induced
Kamilla Gömöri1,2,3,4, Melissa Herwig1,2,3, Roua Hassoun1,2,3
1Department of Cellular and Translational Physiology, Institute of Physiology, Ruhr University Bochum, 44801 Bochum, Germany.
Insights
Volume overload causes heart dysfunction and stiffness by increasing oxidative stress and impairing protein quality control. Glutathione treatment reversed these pathological changes in cardiac remodeling.
Area of Science:
- Cardiology
- Molecular Biology
- Biochemistry
Background:
- Volume overload (VO) is a significant risk factor for cardiac morbidity and mortality.
- Cardiac dysfunction is exacerbated by aging, metabolic issues, and imbalanced cellular redox.
- Understanding early pathological changes in VO is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the early pathological mechanisms of cardiac remodeling in response to volume overload.
- To assess the role of oxidative stress and protein quality control in VO-induced cardiac dysfunction.
- To evaluate the therapeutic potential of glutathione in reversing VO-induced cardiac alterations.
Main Methods:
- Volume overload was induced in Wistar rats via an aortocaval fistula.
- Functional parameters were assessed using transthoracic echocardiography.
- Oxidative stress markers, protein quality control markers (heat shock proteins, caspases), and titin oxidation were analyzed.
Main Results:
- VO induced cardiac hypertrophy, mechanical dysfunction, and increased cardiomyocyte stiffness.
- Elevated oxidative stress markers and impaired protein quality control were observed.
- Glutathione treatment demonstrated a reversal of cardiac dysfunction and associated pathological markers.
- Inflammatory signaling pathways remained unchanged, suggesting a primary role for oxidative stress.
Conclusions:
- Early cardiac response to VO involves mechanical dysfunction and dysregulated signaling pathways.
- Enhanced oxidative stress and impaired protein quality control are key contributors to VO-induced cardiac pathology.
- Glutathione shows promise as a therapeutic agent for mitigating VO-induced cardiac damage.
Abstract:
Volume-induced hypertrophy is one of the risk factors for cardiac morbidity and mortality. In addition, mechanical and metabolic dysfunction, aging, and cellular redox balance are also contributing factors to the disease progression. In this study, we used volume overload (VO), which was induced by an aortocaval fistula in 2-month-old male Wistar rats, and sham-operated animals served as control. Functional parameters were measured by transthoracic echocardiography at termination 4- or 8-months after VO. The animals showed hypertrophic remodeling that was accompanied by mechanical dysfunction and increased cardiomyocyte stiffness. These alterations were reversible upon treatment with glutathione. Cardiomyocyte dysfunction was associated with elevated oxidative stress markers with unchanged inflammatory signaling pathways. In addition, we observed altered phosphorylation status of small heat shock proteins 27 and 70 and diminished protease expression caspases 3 compared to the matched control group, indicating an impaired protein quality control system. Such alterations might be attributed to the increased oxidative stress as anticipated from the enhanced titin oxidation, ubiquitination, and the elevation in oxidative stress markers. Our study showed an early pathological response to VO, which manifests in cardiomyocyte mechanical dysfunction and dysregulated signaling pathways associated with enhanced oxidative stress and an impaired protein quality control system.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Pathophysiology of Cardiac Performance

